These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 381717)

  • 1. [Biological effects and the mechanism of complement activation--cytolytic reactions].
    Inoue K
    Nihon Rinsho; 1979 May; 37(5):1033-7. PubMed ID: 381717
    [No Abstract]   [Full Text] [Related]  

  • 2. The cytolytic attack mechanism of complement.
    Mayer MM
    Monogr Allergy; 1977; 12():1-12. PubMed ID: 335209
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunologically mediated membrane damage: the mechanism of complement action and the similarity of lymphocyte-mediated cytotoxicity.
    Mayer MM; Hammer CH; Michaels DW; Shin ML
    Transplant Proc; 1978 Dec; 10(4):707-14. PubMed ID: 366830
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxic action and other metabolic consequences of terminal complement proteins.
    Shin ML; Carney DF
    Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recent trends in complement research].
    Inai S
    Nihon Rinsho; 1983; 41(4):750-5. PubMed ID: 6350645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP; Wattre P; Santoro F; Capron A
    Lille Med; 1979; 24(7):551-8. PubMed ID: 397392
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes.
    Podack ER
    J Cell Biochem; 1986; 30(2):133-70. PubMed ID: 2422185
    [No Abstract]   [Full Text] [Related]  

  • 9. Membrane attack complex of complement as a pathologic mediator.
    Biesecker G
    Lab Invest; 1983 Sep; 49(3):237-49. PubMed ID: 6193330
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of marker influx into complement-treated resealed erythrocyte ghosts by anti-C5.
    Simone CB; Henkart P
    J Immunol; 1982 Mar; 128(3):1168-75. PubMed ID: 7035559
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement mediated inflammatory reactions.
    Kunkel SL; Fantone JC; Ward PA
    Pathobiol Annu; 1981; 11():127-54. PubMed ID: 6173833
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo decomplementation of guinea pigs with cobra venom factor and anti-C3 serum: analysis of the requirement of C3 and C5 for the mediation of endotoxin-induced death.
    Drake WP; Pokorney DR; Kopyta LP; Mardiney MR
    Biomedicine; 1976 May; 25(3):91-4. PubMed ID: 949521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement, past and present.
    Mayer MM
    Harvey Lect; 1978; 72():139-93. PubMed ID: 374308
    [No Abstract]   [Full Text] [Related]  

  • 16. Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis.
    Morgan BP; Dankert JR; Esser AF
    J Immunol; 1987 Jan; 138(1):246-53. PubMed ID: 3782799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
    Dessauer A; Rother U; Rother K
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
    Balkarowa-Ständer J; Rother U; Rauterberg EW
    J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.